| product Name |
Neoandrographolide |
| Synonyms |
3-[2-[(4aS,5R,8aS)-5,8a-Dimethyl-2-methylidene-5-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-5H-furan-2-one; {(1R,4aS,8aS)-1,4a-dimethyl-6-methylidene-5-[2-(2-oxo-2,5-dihydrofuran-3-yl)ethyl]decahydronaphthalen-1-yl}methyl beta-D-glucopyranoside; (5S,6S,10R)-17-(beta-D-glucopyranosyloxy)-20-oxo-9,19-didehydro-5,6,7,8,9,10,11,12,15-decahydro-20:5,10-dicycloretinal |
| Molecular Formula |
C26H40O8 |
| Molecular Weight |
480.591 |
| InChI |
InChI=1/C26H40O8/c1-15-5-8-19-25(2,14-33-24-22(30)21(29)20(28)18(13-27)34-24)10-4-11-26(19,3)17(15)7-6-16-9-12-32-23(16)31/h9,17-22,24,27-30H,1,4-8,10-14H2,2-3H3/t17-,18-,19-,20-,21+,22-,24-,25+,26+/m1/s1 |
| CAS Registry Number |
27215-14-1 |
| Molecular Structure |
|
| Density |
1.275g/cm3 |
| Boiling point |
668.074°C at 760 mmHg |
| Refractive index |
1.576 |
| Flash point |
220.092°C |
| Vapour Pressur |
0mmHg at 25°C |
| Hazard Symbols |
|
| Risk Codes |
|
| Safety Description |
|
|
